ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout

September 18, 1998

Carter Request Only $878.8 Million For NCI

January 27, 1978

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

October 3, 1997

HAI Delivery Extends Survival In Patients With Liver Metastasis

March 31, 2006

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012